Compare BHC & DXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHC | DXC |
|---|---|---|
| Founded | N/A | 1959 |
| Country | Canada | United States |
| Employees | N/A | 130000 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | 1996 | 2016 |
| Metric | BHC | DXC |
|---|---|---|
| Price | $5.37 | $12.29 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 7 |
| Target Price | $8.33 | ★ $15.33 |
| AVG Volume (30 Days) | ★ 2.5M | 2.3M |
| Earning Date | 05-18-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 423.08 | 356.52 |
| EPS | 0.42 | ★ 0.88 |
| Revenue | $8,724,000,000.00 | ★ $12,871,000,000.00 |
| Revenue This Year | $4.48 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $12.85 | $13.90 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.28 | $11.61 |
| 52 Week High | $8.69 | $17.86 |
| Indicator | BHC | DXC |
|---|---|---|
| Relative Strength Index (RSI) | 33.58 | 41.25 |
| Support Level | N/A | $11.89 |
| Resistance Level | $7.22 | $15.67 |
| Average True Range (ATR) | 0.22 | 0.58 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 21.61 | 35.34 |
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
DXC Technology Co is a vendor-independent IT services provider. The company's operating segment includes Global Business Services (GBS) and Global Infrastructure Services (GIS). It generates maximum revenue from the GIS segment. GIS offerings include Cloud and Security; IT Outsourcing and Modern Workplace. Geographically, it derives a majority of revenue from the Other Europe region.